surface coating

Freudenberg Medical has acquired a 75% stake in Germany-based Hemoteq from Earlybird Venture Capital and Pinova Capital, for an undisclosed amount.

Headquartered in Wurselen, Germany, Hemoteq provides surface coating technologies and related services for combination products such as drug eluting stents, coatings for catheters and cochlear implants, as well as drug-coated balloon catheters.

Under terms of the transaction, Hemoteq founders Michael Hoffmann and Roland Horres will hold the remaining shares, and will collaborate with chief financial officer Thomas Lowen, to manage the company.

"Hemoteq’s coating technology adds a key technology component to our portfolio."

Freudenberg Medical president Jorg Schneewind said: "Hemoteq’s coating technology adds a key technology component to our portfolio and represents an important milestone in our long-term strategy to provide a full suite of innovative technology services to our global medical device OEM customers."

According to Freudenberg, Hemoteq has 100 technology patents in innovative surface technologies. The firm provides comprehensive services, including the development of medical devices, regulatory approval and serial production.

Hemoteq CEO Michael Hoffmann said: "With the combination of our material and processing expertise and Hemoteq’s leading coating technologies, we can provide our customers a unique portfolio of product solutions.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"The long-term orientation and financial stability of Freudenberg assures our customers that we can reliably support them over long development processes and throughout their product life cycles."

Freudenberg develops and manufactures minimally invasive systems, as well as components made of silicone, thermoplastics and speciality metals. Its surfaces can be modified with active-ingredient coatings for optimal efficiency of the medical device.

Image: Hemoteq provides surface coating technologies for medical devices. Photo: courtesy of Business Wire.